Timber Pharmaceuticals Stock Profit Margin
TMBRDelisted Stock | USD 1.72 0.01 0.58% |
Timber Pharmaceuticals fundamentals help investors to digest information that contributes to Timber Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Timber Stock. The fundamental analysis module provides a way to measure Timber Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Timber Pharmaceuticals stock.
Timber |
Timber Pharmaceuticals Company Profit Margin Analysis
Timber Pharmaceuticals' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Timber Pharmaceuticals has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
All Next | Launch Module |
Timber Fundamentals
Return On Equity | -3.43 | |||
Return On Asset | -1.37 | |||
Current Valuation | (916.94 K) | |||
Shares Outstanding | 3.43 M | |||
Shares Owned By Insiders | 1.11 % | |||
Shares Owned By Institutions | 7.78 % | |||
Number Of Shares Shorted | 7.91 K | |||
Price To Book | 6.94 X | |||
Price To Sales | 17.19 X | |||
Revenue | 83.18 K | |||
Gross Profit | (5.26 M) | |||
EBITDA | (19.16 M) | |||
Net Income | (19.38 M) | |||
Cash And Equivalents | 11.22 M | |||
Cash Per Share | 3.78 X | |||
Total Debt | 331.15 K | |||
Debt To Equity | 0.06 % | |||
Current Ratio | 2.45 X | |||
Book Value Per Share | (0.86) X | |||
Cash Flow From Operations | (15.85 M) | |||
Short Ratio | 0.21 X | |||
Earnings Per Share | (1.97) X | |||
Target Price | 11.0 | |||
Beta | -0.65 | |||
Market Capitalization | 1.18 M | |||
Total Asset | 10.28 M | |||
Retained Earnings | (48.26 M) | |||
Working Capital | 4.77 M | |||
Z Score | -10.03 | |||
Net Asset | 10.28 M |
About Timber Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Timber Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Timber Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Timber Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Timber Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Timber Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Timber Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Timber Stock
Moving against Timber Stock
0.81 | KO | Coca Cola Sell-off Trend | PairCorr |
0.8 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.73 | TLK | Telkom Indonesia Tbk | PairCorr |
0.66 | PPERY | Bank Mandiri Persero | PairCorr |
0.64 | PPERF | Bank Mandiri Persero | PairCorr |
The ability to find closely correlated positions to Timber Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Timber Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Timber Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Timber Pharmaceuticals to buy it.
The correlation of Timber Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Timber Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Timber Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Timber Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |